Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rectal Neoplasms 1Prostatic Neoplasms 1Neoplastic Cells, Circulating 1Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Blood Specimen Collection 4Liquid Biopsy 2cabazitaxel 1Sevoflurane 1Radiotherapy 1Propofol 1Positron Emission Tomography Computed Tomography 1Oxaliplatin 1Neoadjuvant Therapy 1Needles 1Microfluidics 1Lymph Node Excision 1Leucovorin 1Laparoscopy 1Ipilimumab 1Histamine H2 Antagonists 1Histamine Antagonists 1Ethiodized Oil 1Epirubicin 1Drug Therapy 1Diagnostic Imaging 1Circulating Tumor DNA 1Chemoembolization, Therapeutic 1Cell-Free Nucleic Acids 1Capecitabine 1CA-72-4 antigen 1CA-19-9 Antigen 1Biopsy, Fine-Needle 1Aspirin 1Antiemetics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplastic Cells, Circulating × Antiemetics × Clear all
NCT03050866 2021-08-20

CABA-V7

Erasmus Medical Center

Phase 2 Unknown
140 enrolled
Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡